INVITRO MEGAKARYOCYTE COLONY FORMATION IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA - DIFFERENCES BETWEEN ACUTE AND CHRONIC ITP

被引:10
作者
ABGRALL, JF
ELKASSAR, N
BERTHOU, C
RENARD, I
CAUVIN, JM
LEPAILLEUR, A
AUTRAND, C
SENSEBE, L
GUERN, G
ZILLIKEN, P
LEGALL, G
BRIERE, J
机构
[1] Department of Hematology, Hǒpital A. Morvan, Brest University, School of Medicine, Brest
来源
INTERNATIONAL JOURNAL OF CELL CLONING | 1992年 / 10卷 / 01期
关键词
IDIOPATHIC THROMBOCYTOPENIC PURPURA; BONE-MARROW; CFU-MEG;
D O I
10.1002/stem.5530100106
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In vitro megakaryocyte colony formation from the bone marrow of patients with acute idiopathic thrombocytopenic purpura (ITP) or chronic ITP was compared using a plasma clot system. The number of megakaryocyte colony-forming units (CFU-Meg) was significantly higher (p < 0.05) in acute ITP compared to chronic ITP (54.3 +/- 68.4 vs. 12.9 +/- 15.3/10(5) nonadherent mononuclear cells, mean +/- SD), and significantly lower (p < 0.05) in chronic ITP compared to controls (12.9 +/- 15.3 vs. 22.8 +/- 15.9). A significant correlation was observed between platelet recovery 7 and 30 days after culture, and the number of CFU-Meg (r = 0.49 and 0.45, respectively, p < 0.05). An inverse correlation was ob. served between platelet count at the time of culture and the number of Megs per colony (r = -0.48, p < 0.05). These results indicated a difference between acute and chronic ITP in the ability to promote in vitro Meg colony formation and may suppose a different immune mechanism for thrombocytopenia in these two disorders.
引用
收藏
页码:28 / 32
页数:5
相关论文
共 9 条
[1]   MEGAKARYOCYTOPOIESIS IN THE MOUSE - RESPONSE TO VARYING PLATELET DEMAND [J].
BURSTEIN, SA ;
ADAMSON, JW ;
ERB, SK ;
HARKER, LA .
JOURNAL OF CELLULAR PHYSIOLOGY, 1981, 109 (02) :333-341
[2]  
DEALARCON PA, 1987, AM J PEDIAT HEMATOL, V9, P212
[3]  
HAN ZC, 1989, EXP HEMATOL, V17, P46
[4]  
KARPATKIN S, 1980, BLOOD, V56, P329
[5]   CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA [J].
MCMILLAN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (19) :1135-1147
[6]  
MCMILLAN R, 1983, CLIN HAEMATOL, V12, P69
[7]  
SEGAL GM, 1986, MEGAKARYOCYTE DEV FU, P341
[8]  
SUGIYAMA H, 1987, ACTA HAEMATOL JAPON, V50, P119
[9]  
TRENT RJ, 1981, CLIN EXP IMMUNOL, V45, P9